Curis, Inc.
61 Moulton Street
Cambridge
Massachusetts
02138
Tel: 617-876-0086
Fax: 617-876-0866
Website: http://www.curis.com/
513 articles about Curis, Inc.
-
Curis, Inc. To Present At Rodman & Renshaw's 8th Annual Healthcare Conference
11/1/2006
-
Curis, Inc. To Release Third Quarter 2006 Financial Results And Hold Conference Call On November 9, 2006
10/31/2006
-
Curis, Inc. To Present At The Mass Opportunities Annual Investors Conference
10/31/2006
-
Curis, Inc. To Present At Biotechnology Industry Organization (BIO) Investor Forum 2006
10/16/2006
-
Curis, Inc. Announces Genentech, Inc. Filing Of Investigational New Drug Application For Systemic Administration Of A Hedgehog Antagonist
10/5/2006
-
Curis, Inc. Issued U.S. Patent Covering Hedgehog Pathway Agonists
10/4/2006
-
Curis, Inc. Agrees To Settlement With Micromet
10/3/2006
-
Curis, Inc. To Present At Noble Financial's Small Cap Conference And Micro Cap Symposium, Titled "OnTrack 2006"
9/21/2006
-
Curis, Inc. Augments Scientific Advisory Board With Leaders In Cancer Research And Development
9/18/2006
-
The Week In Review: A Small Gain Is Still A Gain
9/15/2006
-
Curis, Inc. Named One Of New England's Fastest Growing Life Sciences Companies In Deloitte's Technology Fast 50 Program
9/14/2006
-
Curis, Inc. Announces New Cancer Programs, Formation Of China-Based Subsidiary
9/12/2006
-
Curis, Inc. Determines To Opt Out Of Co-Development Of Basal Cell Carcinoma Drug Candidate
9/1/2006
-
Curis, Inc. Reports Second Quarter 2006 Financial Results
7/27/2006
-
Curis, Inc. To Release Second Quarter 2006 Financial Results And Hold Conference Call On July 27, 2006
7/19/2006
-
Curis, Inc. To Release Second Quarter 2006 Financial Results And Hold Conference Call On July 27, 2006
7/18/2006
-
The Day In Review: Curis, Inc. And Genentech, Inc. Stop Cancer Trial
7/12/2006
-
Curis, Inc. Provides Update On Basal Cell Carcinoma Phase I Clinical Trial; Company To Halt Skin Cancer Drug Trial In Current Formulation
7/12/2006
-
Curis, Inc. Release: Hedgehog Pathway Activation Promotes Coronary Growth
6/22/2006
-
Curis, Inc. Issued U.S. Patent Covering Drug Discovery Assays
6/13/2006